Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ARMO BioSciences, Inc. (ARMO) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/02/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
06/22/2018 4 Xu Stella (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 404,900 shares @ $50, valued at $20.2M
Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
06/22/2018 4 Leveque Joseph (Chief Medical Officer) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Disposed/sold 288,789 options to buy @ $6.9698, valued at $2M
06/22/2018 4 VAN VLASSELAER PETER (President and CEO) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 809,865 shares @ $50, valued at $40.5M
Disposed/sold 190,641 options to buy @ $1.3186, valued at $251.4k
Disposed/sold 220,513 options to buy @ $1.3186, valued at $290.8k
Disposed/sold 398,206 options to buy @ $3.2965, valued at $1.3M
Disposed/sold 216,168 options to buy @ $6.9698, valued at $1.5M
06/22/2018 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 3,709,356 shares @ $50, valued at $185.5M
Unknown transaction of 409,547 shares @ $50, valued at $20.5M
06/22/2018 4 Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
Disposed/sold 55,765 options to buy @ $6.7343, valued at $375.5k
06/22/2018 4 Rizvi Naiyer (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
Disposed/sold 19,146 options to buy @ $6.7343, valued at $128.9k
06/22/2018 4 Kleiner Perkins Caufield & Byers XIV, LLC (10% Owner) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 4,266,683 shares @ $50, valued at $213.3M
06/22/2018 4 CROSS HERB (CFO) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Disposed/sold 240,658 options to buy @ $6.9698, valued at $1.7M
06/22/2018 4 Cui Xiangmin (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 1,214,700 shares @ $50, valued at $60.7M
Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
06/22/2018 4 SEIDENBERG BETH C (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 4,266,683 shares @ $50, valued at $213.3M
Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
06/22/2018 4 GORDON CARL L (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Unknown transaction of 3,709,356 shares @ $50, valued at $185.5M
Unknown transaction of 409,547 shares @ $50, valued at $20.5M
Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
06/22/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/22/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/22/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of ARMO BioSciences, Inc.",
"Amended and Restated Bylaws of ARMO BioSciences, Inc."
06/22/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/22/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/18/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/15/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/15/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/11/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/30/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/30/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/23/2018 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
05/23/2018 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
05/15/2018 10-Q Quarterly Report for the period ended March 31, 2018
05/10/2018 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/10/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Agreement and Plan of Merger by and between Eli Lilly and Company, Bluegill Acquisition Corporation and ARMO BioSciences, Inc.",
"Tender and Support Agreement, by and among Eli Lilly and Company, Bluegill Acquisition Corporation and certain stockholders of ARMO BioSciences, Inc",
"Lilly Announces Agreement To Acquire ARMO BioSciences"
05/10/2018 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
04/02/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 2, 2018 ARMO BIOSCIENCES, INC. Delaware 001-38345 27-3454138 575 Chesapeake Drive Redwood City, CA 94063 94063 779-5075 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 ...",
"ARMO BioSciences Reports FY 2017 Financial Results"
03/30/2018 10-K Annual Report for the period ended December 31, 2017
03/28/2018 4 Xu Stella (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Granted 18,000 options to buy @ $39.97, valued at $719.5k
03/28/2018 4 GORDON CARL L (10% Owner) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Granted 18,000 options to buy @ $39.97, valued at $719.5k
03/28/2018 4 Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Granted 18,000 options to buy @ $39.97, valued at $719.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy